These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 5477806)
1. Observations on the effect of amantadine hydrochloride in the treatment of Parkinsonism. Schwieger AC; Jenkins AC Med J Aust; 1970 Oct; 2(14):630-2. PubMed ID: 5477806 [No Abstract] [Full Text] [Related]
2. Combined treatment of parkinsonism with L-dopa and amantadine. Godwin-Austen RB; Frears CC; Bergmann S; Parkes JD; Knill-Jones RP Lancet; 1970 Aug; 2(7669):383-5. PubMed ID: 4194690 [No Abstract] [Full Text] [Related]
3. Amantadine hydrochloride in the treatment of Parkinsonism. A controlled trial. Appleton DB; Eadie MJ; Sutherland JM Med J Aust; 1970 Oct; 2(14):626-9. PubMed ID: 4920572 [No Abstract] [Full Text] [Related]
4. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride. Reveno WS; Bauer RB; Rosenbaum H Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462 [No Abstract] [Full Text] [Related]
5. Amantadine hydrochloride in the treatment of Parkinson's disease. Gilligan BS; Veale J; Wodak J Med J Aust; 1970 Oct; 2(14):634-7. PubMed ID: 4920573 [No Abstract] [Full Text] [Related]
6. Amantadine hydrochloride in treatment of Parkinsonism. Nagaswami S; Nagaswami R Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280 [No Abstract] [Full Text] [Related]
7. Levodopa and amantadine in the treatment of Parkinsonism. Critchley E Practitioner; 1972 Apr; 208(246):499-504. PubMed ID: 5031037 [No Abstract] [Full Text] [Related]
8. [Experience in the prolonged use of midantan (amantadine hydrochloride) in parkinsonism]. Man'kovskii NB; Vainshtok AB; Oleinik LI Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):524-30. PubMed ID: 4705407 [No Abstract] [Full Text] [Related]
9. L-dopa and amantadine hydrochloride in Parkinson's disease. Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417 [No Abstract] [Full Text] [Related]
10. Use of drugs in the treatment of parkinsonism. Nutr Rev; 1970 Jan; 28(1):7-9. PubMed ID: 4906659 [No Abstract] [Full Text] [Related]
11. Clinical evaluation of amantadine therapy for parkinsonism and the side effects--in cases of thalamic surgery and L-dopa therapy. Matsumoto K; Omoto T; Beck H Folia Psychiatr Neurol Jpn; 1974 Jan; 28(1):1-10. PubMed ID: 4406943 [No Abstract] [Full Text] [Related]
13. Comparison of amantadine, placebo, and levodopa in Parkinson's disease. Bauer RB; McHenry JT Neurology; 1974 Aug; 24(8):715-20. PubMed ID: 4858417 [No Abstract] [Full Text] [Related]
14. L-dopa and amantadine in the therapy of parkinsonism. Weeth JB; Shealy CN; Mercier DA Wis Med J; 1969 Nov; 68(11):325-8. PubMed ID: 4901055 [No Abstract] [Full Text] [Related]
16. Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease. Parkes JD; Baxter RC; Marsden CD; Rees JE J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):422-6. PubMed ID: 4838913 [TBL] [Abstract][Full Text] [Related]
17. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease]. Hacohen H; Gurtner B Schweiz Med Wochenschr; 1972 Apr; 102(16):583-6. PubMed ID: 5019377 [No Abstract] [Full Text] [Related]
18. Amantadine in the treatment of Parkinson's disease. Schwab RS; England AC; Poskanzer DC; Young RR JAMA; 1969 May; 208(7):1168-70. PubMed ID: 5818715 [No Abstract] [Full Text] [Related]
19. Treatment of parkinsonism by amantadine and levodopa. Mawdsley C; Williams IR; Pullar IA; Davidson DL; Kinloch NE Clin Pharmacol Ther; 1972; 13(4):575-83. PubMed ID: 4557584 [No Abstract] [Full Text] [Related]